129 related articles for article (PubMed ID: 15064461)
1. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
Mourez M; Collier RJ
Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
[TBL] [Abstract][Full Text] [Related]
2. Designing a polyvalent inhibitor of anthrax toxin.
Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ
Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of peptide-based anthrax toxin inhibitors.
Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
[TBL] [Abstract][Full Text] [Related]
4. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.
Pini A; Runci Y; Falciani C; Lelli B; Brunetti J; Pileri S; Fabbrini M; Lozzi L; Ricci C; Bernini A; Tonello F; Dal Molin F; Neri P; Niccolai N; Bracci L
Biochem J; 2006 Apr; 395(1):157-63. PubMed ID: 16398644
[TBL] [Abstract][Full Text] [Related]
5. Polyvalency: a promising strategy for drug design.
Vance D; Shah M; Joshi A; Kane RS
Biotechnol Bioeng; 2008 Oct; 101(3):429-34. PubMed ID: 18727104
[TBL] [Abstract][Full Text] [Related]
6. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
Gujraty KV; Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
Biomacromolecules; 2006 Jul; 7(7):2082-5. PubMed ID: 16827573
[TBL] [Abstract][Full Text] [Related]
8. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.
Huang BC; Liu R
Biochemistry; 2007 Sep; 46(35):10102-12. PubMed ID: 17685586
[TBL] [Abstract][Full Text] [Related]
10. Polyvalent inhibitors of anthrax toxin that target host receptors.
Basha S; Rai P; Poon V; Saraph A; Gujraty K; Go MY; Sadacharan S; Frost M; Mogridge J; Kane RS
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13509-13. PubMed ID: 16938891
[TBL] [Abstract][Full Text] [Related]
11. Self-association of the transmembrane domain of an anthrax toxin receptor.
Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
[TBL] [Abstract][Full Text] [Related]
12. Phage display and crystallographic analysis reveals potential substrate/binding site interactions in the protein secretion chaperone CsaA from Agrobacterium tumefaciens.
Feldman AR; Shapova YA; Wu SS; Oliver DC; Heller M; McIntosh LP; Scott JK; Paetzel M
J Mol Biol; 2008 Jun; 379(3):457-70. PubMed ID: 18462752
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
14. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
Steiniger SC; Altobell LJ; Zhou B; Janda KD
Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
[TBL] [Abstract][Full Text] [Related]
15. REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors.
Andrews MJ; Kontopidis G; McInnes C; Plater A; Innes L; Cowan A; Jewsbury P; Fischer PM
Chembiochem; 2006 Dec; 7(12):1909-15. PubMed ID: 17051658
[TBL] [Abstract][Full Text] [Related]
16. Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
Kuzmic P; Cregar L; Millis SZ; Goldman M
FEBS J; 2006 Jul; 273(13):3054-62. PubMed ID: 16817854
[TBL] [Abstract][Full Text] [Related]
17. Interactions between peptides containing nucleobase amino acids and T7 phages displaying S. cerevisiae proteins.
Watanabe S; Tomizaki KY; Takahashi T; Usui K; Kajikawa K; Mihara H
Biopolymers; 2007; 88(2):131-40. PubMed ID: 17206624
[TBL] [Abstract][Full Text] [Related]
18. Designing scaffolds of peptides for phage display libraries.
Uchiyama F; Tanaka Y; Minari Y; Tokui N
J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
[TBL] [Abstract][Full Text] [Related]
19. Phage display identification of functional binding peptides against 4-acetamidophenol (Paracetamol): an exemplified approach to target low molecular weight organic molecules.
Smith MW; Smith JW; Harris C; Brancale A; Allender CJ; Gumbleton M
Biochem Biophys Res Commun; 2007 Jun; 358(1):285-91. PubMed ID: 17482566
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
Han Z; Simpson JT; Fivash MJ; Fisher R; Mori T
Peptides; 2004 Apr; 25(4):551-61. PubMed ID: 15165709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
